SCHEMBL6345977

SCHEMBL6345977

CC(C)C(=O)c1ccc2c([N+](=O)[O-])c(O)c(O)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ COMT P21964 6/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ DBH P09172 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ PDK1 Q15118 3/20 0.37
▸ TTR P02766 2/20 0.37
▸ ABCC3 O15438 1/20 0.37
▸ ABCC4 O15439 1/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ ABCB11 O95342 1/20 0.37
▸ NR3C1 P04150 1/20 0.37
▸ PGR P06401 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ RARB P10826 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6345493 0.83 COMT (0.48) COMTKDM4EGAAESR1ESR2
SCHEMBL6346541 0.78 MAPK1 (0.48) COMTDBHTTRABCC3ABCC4
SCHEMBL31514936 0.78 COMT (0.70) COMTRECQL
SCHEMBL6339877 0.76 COMT (0.47) COMTKDM4ERECQLESR1ESR2
SCHEMBL6339442 0.75 COMT (0.47) COMTFFAR1
SCHEMBL6345825 0.75 HPGD (0.51) COMT
SCHEMBL6339883 0.75 COMT (0.47) COMTFFAR1
SCHEMBL6339917 0.75 S100A4 (0.58) COMTKDM4EGAARECQLESR1
SCHEMBL6940583 0.72 COMT (0.44) COMTESR1ESR2S100A4MCL1
SCHEMBL6349986 0.71 CYP3A4 (0.67) COMTESR1ESR2GPR35S100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903114-B2 Derivatives of naphthalene with COMT inhibiting activity ORION CORPORATION (FI) 2005-06-07 — — US disclosed
US-20040034011-A1 Derivatives of naphthalene with comt inhibiting activity ORION CORPORATION (FI) 2004-02-19 — — US disclosed
EP-1317411-A1 DERIVATIVES OF NAPHTHALENE WITH COMT INHIBITING ACTIVITY ORION CORPORATION (FI) 2003-06-11 — — EP disclosed
WO-2002022551-A1 DERIVATIVES OF NAPHTHALENE WITH COMT INHIBITING ACTIVITY ORION CORPORATION (FI) 2002-03-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034011-A1 Derivatives of naphthalene with comt inhibiting activity COMT, CYP1A1, CYP1B1 COMT 1/4885KDM4E 2965/4885DBH 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback